Recursion RXRX Earnings Preview: Oncology and Rare Disease Updates Expected

Second-Quarter Earnings Call Scheduled for August 8th

WEB Recursion RXRX is expected to provide updates on its oncology and rare disease clinical-stage pipeline in its second-quarter earnings call. The company is scheduled to host a public Learnings call on August 8th, 2024, at 5:00 pm ET (3:00 pm MT).

Beat Earnings Expectations

Recursion RXRX, a TechBio company specializing in decoding biology and chemistry for drug discovery, is likely to beat earnings expectations, according to analysts' estimates. The company has a robust pipeline of oncology and rare disease candidates, and investors will be eager to hear updates on the progress of these programs.